Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
An update from Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh ( (AU:IMR) ) is now available.
Imricor Medical Systems, Inc. held its Annual General Meeting in May 2025, providing a general overview of the company’s activities and financial information. The presentation highlighted the company’s reliance on the safe harbor provisions of Regulation S under the US Securities Act for trading its CHESS Depositary Interests on the ASX. The release emphasized the importance of not placing undue reliance on forward-looking statements due to the current economic climate and the ongoing impact of the COVID-19 pandemic.
The most recent analyst rating on (AU:IMR) stock is a Buy with a A$2.28 price target. To see the full list of analyst forecasts on Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh stock, see the AU:IMR Stock Forecast page.
More about Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh
Imricor Medical Systems, Inc. operates in the medical technology industry, focusing on developing and commercializing MRI-compatible products for cardiac catheter ablation procedures. The company aims to enhance the safety and efficacy of these procedures by integrating MRI technology, which provides superior imaging capabilities compared to traditional methods.
Average Trading Volume: 426,724
See more data about IMR stock on TipRanks’ Stock Analysis page.